We expect Amgen AMGN to beat expectations when it reports second-quarter 2025 results on Aug. 5 after market close. In the ...

Review Denali Therapeutics Inc (DNLI:XNAS) stock and the current sustainability and ESG risk rating to help with your investing decisions.

Alector’s 71% drop prompts a fresh look at its valuation, financials, and pipeline to gauge recovery prospects amid lingering ...